Yoshihei Hirasawa - Concepedia

Author

Yoshihei Hirasawa

Shinrakuen Hospital

Also Known As

H Shirasu, Y HIRASAWA, Y Hirasawa, Y. HIRASAWA, Y. Hirasawa, YOSHIHEI HIRASAWA, Yoshihei HIRASAWA, Yoshihei Hirasawa

128

Publications

2.7K

Citations

H-Index

Concepts

All Affiliations

Shinrakuen Hospital Niigata University Nagoya University Hospital Showa University Fujigaoka Hospital Toranomon Hospital

About

Yoshihei Hirasawa is an author at Shinrakuen Hospital specializing in medicine, chronic kidney disease, and hemodialysis.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	20	25	2.4K
2	Health Sciences	2	2	65
3	Allergy	2	2	41
4	Public Health	1	1	49
5	Social Sciences	1	1	16

Yoshihei Hirasawa

Publications

2.5K

Citations

H-Index

Page 1

	Year	Citations
A new form of amyloid protein associated with chronic hemodialysis was identified as β2-microglobulin F Gejyo, Takao Yamada, Sumiko Odani, Biochemical and Biophysical Research Communications HemodialysisUrologyNew FormBiochemistryAmyloid Protein	1985	986
β2-microglobulin: A new form of amyloid protein associated with chronic hemodialysis Fumitake Gejyo, Shoji Odani, Toshiyuki Yamada, Kidney International HemodialysisUrologyNew FormBiochemistryAmyloid Protein	1986	265
Switch from conventional to high-flux membrane reduces the risk of carpal tunnel syndrome and mortality of hemodialysis patients Yutaka Koda, Shinichi Nishi, Shigeru Miyazaki, Kidney International HemodialysisHemodialysis PatientsMedicineCarpal Tunnel SyndromeHigh-flux Membrane	1997	229
Depressant action of acetate upon the human cardiovascular system. Yoshiyasu Aizawa, Takashi Ohmori, Kentaro Imai, PubMed HypertensionHeart FailureCardiovascular PharmacologyDialysis TherapyCardiovascular Function	1977	139
Histochemical and immunohistochemical characterization of amyloid associated with chronic hemodialysis as beta 2-microglobulin. T Shirahama, M Skinner, Alan S. Cohen, PubMed HemodialysisAlzheimer's DiseaseBiochemistryMedicineRenal Pathology	1985	100
Nafamostat Mesilate: A Regional Anticoagulant for Hemodialysis in Patients at High Risk for Bleeding Tadao Akizawa, Shozo Koshikawa, Kazuo Ota, The Nephron journals/Nephron journals DialysisDialysis TherapyHemodialysis PatientsRegional AnticoagulantThrombosis	1993	93
L-Carnitine Supplementation Decreases the Left Ventricular Mass in Patients Undergoing Hemodialysis Tai Sakurabayashi, Shigeru Miyazaki, Yasuko Yuasa, Circulation Journal	2008	57
Amyloidosis of a possible new type in patients receiving long-term hemodialysis. Tomotake Morita, Miho Suzuki, Akiko Kamimura, PubMed DialysisRenal PathologyCarpal Tunnel SyndromeDialysis TherapyBiomedical Engineering	1985	54
Immunohistochemical detection of advanced glycation end products in dialysis-related amyloidosis Toshimitsu Niwa, Shigeru Miyazaki, Tomoyuki Katsuzaki, Kidney International Alzheimer's DiseaseBiochemistryMedicineBioanalysisGlycobiology	1995	52
Dialysis-related amyloidosis of the heart in long-term hemodialysis patients Fumio Takayama, Shigeru Miyazaki, Takashi Morita, Kidney International HemodialysisUrologyHeart FailureCardiorenal SyndromesMedicine	2001	49

Page 1